Related Experiment Videos
[Pharmaceutical procurement by the public sector: the quality/cost relationship]
V L Luiza1, C G Castro, J M Nunes
1Serviço de Farmácia, Hospital Evandro Chagas, Fundação Oswaldo Cruz, Av. Brasil 4365, Manguinhos, Rio de Janeiro, RJ 21045-900, Brasil. vera@fiocruz.br
Cadernos De Saude Publica
|January 14, 2000
Summary
This study examines pharmaceutical procurement in public health, focusing on ensuring drug quality and managing costs. It offers strategies for acquiring high-quality, cost-effective medicines through informed supply chain management.
Area of Science:
- Pharmaceutical Sciences
- Health Management
- Supply Chain Logistics
Context:
- Public health sector procurement of pharmaceutical products.
- Focus on supply management for essential medicines.
- Balancing drug quality and cost-effectiveness.
Purpose:
- To analyze key considerations for buyers in evaluating pharmaceutical quality, including formulation stability and bioequivalence.
- To examine cost management factors influenced by technological advancements and consumer needs.
- To present novel strategies for procuring high-quality, cost-effective pharmaceutical products.
Summary:
- The article delves into pharmaceutical procurement within the public health sector, emphasizing supply chain management.
- It scrutinizes drug quality assessment, covering formulation stability, bioequivalence, and the role of generic drugs.
- Cost factors, technological innovation, and consumer demand are analyzed, with suggestions for optimizing procurement.
Impact:
- Informs public health policy on pharmaceutical sourcing.
- Aids in developing efficient and cost-effective drug procurement strategies.
- Contributes to ensuring access to quality medicines in the public health domain.